Similar articles for PMID: 32370577

1

Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.

Hou W, Zhang W, Jin R, Liang L, Xu B, Hu Z. Hou W, et al. Infect Dis (Lond). 2020 Jul;52(7):498-505. doi: 10.1080/23744235.2020.1759817. Epub 2020 May 6. Infect Dis (Lond). 2020. PMID: 32370577 Free PMC article.

2

Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.

Cheng B, Hu J, Zuo X, Chen J, Li X, Chen Y, Yang G, Shi X, Deng A. Cheng B, et al. Clin Microbiol Infect. 2020 Oct;26(10):1400-1405. doi: 10.1016/j.cmi.2020.06.033. Epub 2020 Jul 2. Clin Microbiol Infect. 2020. PMID: 32622952 Free PMC article.

3

A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.

Yang M, Chen X, Xu Y. Yang M, et al. Med Sci Monit. 2020 Sep 11;26:e926393. doi: 10.12659/MSM.926393. Med Sci Monit. 2020. PMID: 32914767 Free PMC article.

4

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.

Pan F, Yang L, Li Y, Liang B, Li L, Ye T, Li L, Liu D, Gui S, Hu Y, Zheng C. Pan F, et al. Int J Med Sci. 2020 May 18;17(9):1281-1292. doi: 10.7150/ijms.46614. eCollection 2020. Int J Med Sci. 2020. PMID: 32547323 Free PMC article.

5

Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.

Wang H, Zhang Y, Mo P, Liu J, Wang H, Wang F, Zhao Q. Wang H, et al. Int Immunopharmacol. 2020 Aug;85:106683. doi: 10.1016/j.intimp.2020.106683. Epub 2020 Jun 6. Int Immunopharmacol. 2020. PMID: 32531713 Free PMC article.

6

Clinical progression of patients with COVID-19 in Shanghai, China.

Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, Li F, Xu Q, Zhang Y, Xu S, Song Z, Zeng Y, Shen Y, Shi Y, Zhu T, Lu H. Chen J, et al. J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19. J Infect. 2020. PMID: 32171869 Free PMC article.

7

The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China.

Wang F, Qu M, Zhou X, Zhao K, Lai C, Tang Q, Xian W, Chen R, Li X, Li Z, He Q, Liu L. Wang F, et al. J Transl Med. 2020 Jul 3;18(1):270. doi: 10.1186/s12967-020-02423-8. J Transl Med. 2020. PMID: 32620125 Free PMC article.

8

Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.

Zhou Y, Zhang Z, Tian J, Xiong S. Zhou Y, et al. Ann Palliat Med. 2020 Mar;9(2):428-436. doi: 10.21037/apm.2020.03.26. Epub 2020 Mar 17. Ann Palliat Med. 2020. PMID: 32233642 Free article.

9

C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.

Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, Jiang X, Li X. Tan C, et al. J Med Virol. 2020 Jul;92(7):856-862. doi: 10.1002/jmv.25871. Epub 2020 Apr 25. J Med Virol. 2020. PMID: 32281668 Free PMC article.

10

Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.

Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Zhang Y, et al. Liver Int. 2020 Sep;40(9):2095-2103. doi: 10.1111/liv.14455. Epub 2020 Apr 28. Liver Int. 2020. PMID: 32239796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Filters